ArticleClinical Medicine Insights. Oncology2022

Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report.

Ling Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.